Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Colorectal Neoplasms

  Free Subscription


21.01.2019

3 Ann Surg
1 Ann Surg Oncol
5 Anticancer Res
4 BMC Cancer
1 Br J Cancer
2 Cancer Res
1 Dis Colon Rectum
2 Gastroenterology
1 Int J Cancer
1 Int J Colorectal Dis
1 J Natl Cancer Inst
3 J Surg Oncol
1 Lancet Infect Dis
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg

  1. FRETLAND AA, Dagenborg VJ, Bjornelv GMW, Kazaryan AM, et al
    Laparoscopic Versus Open Resection for Colorectal Liver Metastases: The OSLO-COMET Randomized Controlled Trial.
    Ann Surg. 2018;267:199-207.
    PubMed     Text format     Abstract available

  2. KIM MJ, Park SC, Park JW, Chang HJ, et al
    Robot-assisted Versus Laparoscopic Surgery for Rectal Cancer: A Phase II Open Label Prospective Randomized Controlled Trial.
    Ann Surg. 2018;267:243-251.
    PubMed     Text format     Abstract available

  3. BUCHLI C, Martling A, Abani MA, Frodin JE, et al
    Risk of Acute Testicular Failure After Preoperative Radiotherapy for Rectal Cancer: A Prospective Cohort Study.
    Ann Surg. 2018;267:326-331.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  4. SOLOMON D, DeNicola NL, Feferman Y, Bekhor E, et al
    More Synchronous Peritoneal Disease but Longer Survival in Younger Patients with Carcinomatosis from Colorectal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2019 Jan 14. pii: 10.1245/s10434-018-07087.
    PubMed     Text format     Abstract available


    Anticancer Res

  5. KIM J, Ahn S, Kim K, Cho MS, et al
    Prognostic Significance of Survivin Expression and Combined Analysis with Cancer Stem Cell and Epithelial-Mesenchymal Transition-related Markers in Patients with Rectal Cancer Undergoing Preoperative Chemoradiotherapy.
    Anticancer Res. 2018;38:6881-6889.
    PubMed     Text format     Abstract available

  6. MORELLI C, Formica V, Pellicori S, Menghi A, et al
    Chemotherapy in Patients with Hereditary Angioedema.
    Anticancer Res. 2018;38:6801-6807.
    PubMed     Text format     Abstract available

  7. RADES D, Vogelsang RP, Treder M, Janssen S, et al
    A Matched-Pair Study Comparing Surgery Plus Neoadjuvant Radio-Chemotherapy and Surgery Alone for High Rectal Cancers.
    Anticancer Res. 2018;38:6877-6880.
    PubMed     Text format     Abstract available

  8. LEE JH, Song C, Kang SB, Lee HS, et al
    Predicting Pathological Complete Regression with Haematological Markers During Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
    Anticancer Res. 2018;38:6905-6910.
    PubMed     Text format     Abstract available

  9. KOH HK, Kim K, Jang WI, Song CH, et al
    Radiation Therapy for Anal Squamous Cell Carcinoma: A Retrospective Multicenter Study.
    Anticancer Res. 2018;38:6931-6938.
    PubMed     Text format     Abstract available


    BMC Cancer

  10. CAI SR, Huang YQ, Zhang SZ, Li QL, et al
    Effects of subitems in the colorectal cancer screening protocol on the Chinese colorectal cancer screening program: an analysis based on natural community screening results.
    BMC Cancer. 2019;19:47.
    PubMed     Text format     Abstract available

  11. VANIA L, Rebelo TM, Ferreira E, Weiss SFT, et al
    Knock-down of LRP/LR promotes apoptosis in early and late stage colorectal carcinoma cells via caspase activation.
    BMC Cancer. 2018;18:602.
    PubMed     Text format     Abstract available

  12. KIM SC, Shin YK, Kim YA, Jang SG, et al
    Identification of genes inducing resistance to ionizing radiation in human rectal cancer cell lines: re-sensitization of radio-resistant rectal cancer cells through down regulating NDRG1.
    BMC Cancer. 2018;18:594.
    PubMed     Text format     Abstract available

  13. REYNOLDS LM, Bissett IP, Consedine NS
    Emotional predictors of bowel screening: the avoidance-promoting role of fear, embarrassment, and disgust.
    BMC Cancer. 2018;18:518.
    PubMed     Text format     Abstract available


    Br J Cancer

  14. VARKARIS A, Katsiampoura A, Davis JS, Shah N, et al
    Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer.
    Br J Cancer. 2019 Jan 14. pii: 10.1038/s41416-018-0360.
    PubMed     Text format     Abstract available


    Cancer Res

  15. TOMMELEIN J, De Vlieghere E, Verset L, Melsens E, et al
    Radiotherapy-Activated Cancer-Associated Fibroblasts Promote Tumor Progression through Paracrine IGF1R Activation.
    Cancer Res. 2018;78:659-670.
    PubMed     Text format     Abstract available

  16. CHOWELL D, Napier J, Gupta R, Anderson KS, et al
    Modeling the Subclonal Evolution of Cancer Cell Populations.
    Cancer Res. 2018;78:830-839.
    PubMed     Text format     Abstract available


    Dis Colon Rectum

  17. VU JV, Matusko N, Hendren S, Regenbogen SE, et al
    Patient-Reported Unmet Needs in Colorectal Cancer Survivors After Treatment for Curative Intent.
    Dis Colon Rectum. 2019 Jan 9. doi: 10.1097/DCR.0000000000001326.
    PubMed     Text format     Abstract available


    Gastroenterology

  18. KWONG TNY, Wu WKK, Wong SH
    Reply.
    Gastroenterology. 2019;156:292.
    PubMed     Text format    

  19. WONG HK, Ho PL, Lee CK
    Streptococcus gallolyticus Bacteremia and Colorectal Carcinoma.
    Gastroenterology. 2019;156:291-292.
    PubMed     Text format    


    Int J Cancer

  20. CHENG X, Jin Z, Ji X, Shen X, et al
    ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet-derived growth factor BB.
    Int J Cancer. 2019 Jan 16. doi: 10.1002/ijc.32071.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  21. HOSHINO N, Fukui Y, Hida K, Sakai Y, et al
    Short-term outcomes of laparoscopic surgery for colorectal cancer in the elderly versus non-elderly: a systematic review and meta-analysis.
    Int J Colorectal Dis. 2019 Jan 16. pii: 10.1007/s00384-019-03234.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  22. GRAY V, Briggs S, Palles C, Jaeger E, et al
    Pattern Recognition Receptor Polymorphisms as Predictors of Oxaliplatin Benefit in Colorectal Cancer.
    J Natl Cancer Inst. 2019 Jan 14. pii: 5289445. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Surg Oncol

  23. LEIJSSEN LGJ, Dinaux AM, Amri R, Taylor MS, et al
    Impact of intramural and extramural vascular invasion on stage II-III colon cancer outcomes.
    J Surg Oncol. 2019 Jan 15. doi: 10.1002/jso.25367.
    PubMed     Text format     Abstract available

  24. FIELDS AC, McCarty JC, Ma-Pak L, Lu P, et al
    New lymph node staging for rectal neuroendocrine tumors.
    J Surg Oncol. 2019;119:156-162.
    PubMed     Text format     Abstract available

  25. FLYNN SM, Burchette RJ, Ghassemi M, Ratner O, et al
    Carnoy's solution fixation with compression significantly increases the number of lymph nodes yielded from colorectal cancer specimens.
    J Surg Oncol. 2019 Jan 16. doi: 10.1002/jso.25372.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  26. WIELAND U, Kreuter A
    The importance of HPV16 in anal cancer prevention.
    Lancet Infect Dis. 2018;18:131-132.
    PubMed     Text format    


    PLoS One

  27. SARTOR ITS, Recamonde-Mendoza M, Ashton-Prolla P
    TULP3: A potential biomarker in colorectal cancer?
    PLoS One. 2019;14:e0210762.
    PubMed     Text format     Abstract available

  28. LEE YH, Kung PT, Wang YH, Kuo WY, et al
    Effect of length of time from diagnosis to treatment on colorectal cancer survival: A population-based study.
    PLoS One. 2019;14:e0210465.
    PubMed     Text format     Abstract available

  29. SOMMER CA, Capilla A, Molina-Estevez FJ, Gianotti-Sommer A, et al
    Modeling APC mutagenesis and familial adenomatous polyposis using human iPS cells.
    PLoS One. 2018;13:e0200657.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: